INDOCID Retard caps ret 75 mg 20 pce

7680404540123 CH-40454 M01AB01 07.10.1.
INDOCID Retard caps ret 75 mg 20 pce
INDOCID Retard caps ret 75 mg 20 pce
INDOCID Retard caps ret 75 mg 20 pce
1 / 3
google

Details

Product number
4045401
CPT
-
Packaging group
20
Unit
Kapsel(n)
Composition
indometacinum 75 mg, saccharum 102.29 mg, maydis amylum, cellulosum microcristallinum, hypromellosum, magnesii stearas, poly(vinylis acetas), E 132, Kapselhülle: gelatina, E 171, E 172 (flavum), pro capsula.

Articles (1)

Indocid-Retard, Kapseln
Kapseln
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/11/2024
Patient information leaflet
Français
08/11/2024
Patient information leaflet
Italien
08/11/2024
Professional SmPC
Allemand
08/11/2024
Professional SmPC
Français
08/11/2024
Professional SmPC
Italien
08/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
102.29 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 14.40
Specialties list
Yes
Generic
No
SL addition date: 15/03/1965

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
40454
Drug name
Indocid-Retard, Kapseln
Galenic form
RETH
ATC Code
M01AB01
Authorization status
Z
Dispensation category
B
First authorization
27/06/1977
Authorization expiration date
31/12/9999
IT number
07.10.1.
Domain
Human medicine
Field of application
Antirheumaticum

Packaging details

Description (FR)
INDOCID Retard caps ret 75 mg 20 pce
Description (DE)
INDOCID Retard Ret Kaps 75 mg 20 Stk
Market launch
27/06/1977
Narcotic (BTM)
No

Other packaging sizes